1. PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

   • Soheila Fattahi
   • Zahra Khalifehzadeh-Esfahani
   • Morteza Jafarinia

   Review 02 February 2022 Pages: 269 - 275

   

2. Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases

   • Ning Shi
   • Zhihong Wang
   • Longlong Luo

   Review Open access 11 February 2022 Pages: 276 - 288

   

3. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review

   • Swarnali Das
   • Suvrendu Sankar Kar
   • Sandeep Kumar Dash

   Review 22 February 2022 Pages: 289 - 315

   

4. An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19

   • Pooria Fazeli
   • Mohammadreza Saeidnia
   • Mehdi Kalani

   Review 08 March 2022 Pages: 316 - 324

   

5. Association of IGHM polymorphisms with susceptibility to type 1 diabetes

   • Zouidi Ferjeni
   • Fakhfakh Raouia
   • H. Masmoudi

   Original Article 20 January 2022 Pages: 325 - 330

   

6. Microarray profiling and functional analysis reveal the regulatory role of differentially expressed plasma circular RNAs in Hashimoto’s thyroiditis

   • Xuefeng Bai
   • Meirong Huang
   • Huibin Huang

   Original Article 22 January 2022 Pages: 331 - 340

   

7. CircCBFB is a mediator of hepatocellular carcinoma cell autophagy and proliferation through miR-424-5p/ATG14 axis

   • Zidan Zhao
   • Junjian He
   • Chao Feng

   Original Article 23 January 2022 Pages: 341 - 353

   

8. Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-γ production via metabolism-related compound library screening

   • Qinglan Yang
   • Shuju Zhang
   • Youcai Deng

   Original Article Open access 15 February 2022 Pages: 354 - 364

   

9. Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis

   • Cornelia Lackner
   • Michael Karbiener
   • Thomas R. Kreil

   Original Article Open access 09 March 2022 Pages: 365 - 370

   

10. Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor

    • Shelby M. Knoche
    • Alaina C. Larson
    • Joyce C. Solheim

    Original Article 18 March 2022 Pages: 371 - 391

    

11. H19 is involved in the regulation of inflammatory responses in acute gouty arthritis by targeting miR-22-3p

    • Yan-Yan Xue
    • Hui-Jie Liu
    • Ping Shao

    Original Article 21 March 2022 Pages: 392 - 399

    

12. Association of the MARCO polymorphism rs6761637 with hepatocellular carcinoma susceptibility and clinical characteristics

    • Zhenzhen Su
    • Limei Luo
    • Bei Cai

    Original Article 01 April 2022 Pages: 400 - 407

    

13. Peripheral neuropathies during the COVID-19 pandemic: is there a relation?

    • Milena Trentinaglia
    • Giuseppe Lippi
    • Sara Mariotto

    Brief Report 03 March 2022 Pages: 408 - 413

14. Multimodal immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated multiorgan autoimmunity

    • Hiroo Kasahara
    • Kazuki Shimizu
    • Yoshio Ikeda

    Brief Report 14 March 2022 Pages: 414 - 418